Scott Skibo
Pulmonary Disease · Pinehurst, NCNPI 1063431849
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $170,280 of the $229,280 with a category attached, or 74.3%. 17 manufacturers reported payments, led by GSK at 39.5% of the total. Reporting peaked in 2019 at $91,564 and has fallen 98.7% since, to $1,220 in 2025. Among pulmonary disease clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 264 payments — averaging $868.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$91K
- AstraZeneca$87K
- Covidien LP$31K
- Medtronic$14K
- Viiv Healthcare Company$2K
- Intuitive Surgical$1K
- plus $3K from 11 others
Across 1 payment — averaging $2040.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$2K
What the payments were for
- Consulting fees$36,12516%
- Speaking & faculty fees$170,28074%
- Travel & lodging$18,3388%
- Food & beverage$4,5282%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 68 | $90,674 |
| AstraZeneca | 109 | $86,929 |
| Covidien LP | 41 | $31,060 |
| Medtronic | 19 | $14,280 |
| Viiv Healthcare Company | 1 | $1,600 |
| Intuitive Surgical | 5 | $1,427 |
| Astrazeneca UK Limited | 1 | $1,011 |
| GE HealthCare | 2 | $953 |
| Johnson & Johnson | 4 | $332 |
| Auris Health, Inc. | 2 | $221 |
| Noah Medical Corporation | 4 | $201 |
| Broncus Medical | 1 | $177 |
| Healthmyne, Inc. | 2 | $154 |
| Boston Scientific | 2 | $83 |
| Boehringer Ingelheim | 1 | $77 |
| Gyrus ACMI, Inc. | 1 | $75 |
| Siemens Medical Solutions USA, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$75,971
- TRELEGY ELLIPTA$75,424
- superDimension$32,386
- ANORO ELLIPTA$14,563
- TAGRISSO$9,794
- Da Vinci Surgical System$1,408
- SUPERLOCK$1,020
- Monarch Platform$236
- HealthMyne$133
- MONARCH$122
How this compares
$229,280 in reported general payments places this provider in the 95th percentile of 393 pulmonary disease providers in North Carolina.
Other pulmonary disease in Pinehurst
- Michael PritchettPinehurst$1.3M
- Bradley IcardPinehurst$299K
- Adam BelangerPinehurst$96K
- Scott JohnsonPinehurst$24K
- Michael WertGreensboro$412K
- Eugene BleeckerWinston Salem$357K
- James DonohueChapel Hill$271K
- Eric MeltzerDurham$262K
- Daniel BreaultWilmington$257K
- Jill OharWinston Salem$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.